Canada · Health Canada Drug Product Database
SANDOSTATIN LAR
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 62793
- DIN
- 02239324
- Form
- Powder For Suspension (Sustained-Release
- Company as listed by source
- NOVARTIS PHARMACEUTICALS CANADA INC
- Source status
- Marketed (1999-01-27)
- Source last updated
- 2026-03-17
Source-listed ingredients
- OCTREOTIDE (OCTREOTIDE ACETATE) — 20 MG — per 1 VIAL
These values do not establish equivalence or a dose recommendation.
Packages
- 2ml
Source and coverage
Open Health Canada Drug Product Database →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse Canada records →